Takeshi Suda

Summary

Affiliation: Niigata University
Country: Japan

Publications

  1. pmc Active treatments are a rational approach for hepatocellular carcinoma in elderly patients
    Takeshi Suda
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Chuo Ku, Niigata, Niigata 951 8122, Japan
    World J Gastroenterol 19:3831-40. 2013
  2. ncbi request reprint Interchromosomal telomere length variation
    Takeshi Suda
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1 757 Asahimachi dori, Niigata 951 8122, Japan
    Biochem Biophys Res Commun 291:210-4. 2002
  3. pmc A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
    Akihiko Osaki
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University Niigata, Niigata 951 8510, Japan
    Cancer Med 2:86-98. 2013
  4. ncbi request reprint Interferon can block telomere erosion and in rare cases result in hepatocellular carcinoma development with telomeric repeat binding factor 1 overexpression in chronic hepatitis C
    Masato Igarashi
    Division of Gastroenterology and Hepatology, Department of Cellular Function, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
    Clin Cancer Res 9:5264-70. 2003
  5. ncbi request reprint Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation
    Nobuo Waguri
    Division of Gastroenterology and Hepatology, Department of Cellular Function, Graduate School of Medical and Dental Science, Niigata University, Niigata 951 8122, Japan
    Clin Cancer Res 9:3004-11. 2003
  6. pmc Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma
    Kenya Kamimura
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan
    BMC Gastroenterol 12:127. 2012
  7. ncbi request reprint Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis C
    Yasushi Tamura
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan
    Dig Dis Sci 54:2530-7. 2009
  8. pmc Shear wave velocity is a useful marker for managing nonalcoholic steatohepatitis
    Akihiko Osaki
    Department of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1 757 Asahimachi dori, Chuo Ku, Niigata, Niigata 951 8122, Japan
    World J Gastroenterol 16:2918-25. 2010
  9. pmc Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis
    Hirokazu Kawai
    Hirokazu Kawai, Department of Clinical Laboratory, Niigata University Medical and Dental Hospital, Niigata 951 8510, Japan
    World J Hepatol 3:15-23. 2011
  10. doi request reprint Formula to predict platelet count after partial splenic arterial embolization in patients with hypersplenism
    Akihiko Osaki
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1 757 Asahimachi dori, Chuo Ku, Niigata, Niigata 951 8122, Japan
    J Vasc Interv Radiol 23:900-7. 2012

Collaborators

Detail Information

Publications31

  1. pmc Active treatments are a rational approach for hepatocellular carcinoma in elderly patients
    Takeshi Suda
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Chuo Ku, Niigata, Niigata 951 8122, Japan
    World J Gastroenterol 19:3831-40. 2013
    ..To determine whether an active intervention is beneficial for the survival of elderly patients with hepatocellular carcinoma (HCC)...
  2. ncbi request reprint Interchromosomal telomere length variation
    Takeshi Suda
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1 757 Asahimachi dori, Niigata 951 8122, Japan
    Biochem Biophys Res Commun 291:210-4. 2002
    ..This is the first description of an association between telomere length and chromosome size...
  3. pmc A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
    Akihiko Osaki
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University Niigata, Niigata 951 8510, Japan
    Cancer Med 2:86-98. 2013
    ..73 m(2)) upon an assumption of HCC doubling time of 90 days, and the targeted liver is smaller than 200 times the CDDP dose (mg). A further analysis is required to define appropriate injection speeds...
  4. ncbi request reprint Interferon can block telomere erosion and in rare cases result in hepatocellular carcinoma development with telomeric repeat binding factor 1 overexpression in chronic hepatitis C
    Masato Igarashi
    Division of Gastroenterology and Hepatology, Department of Cellular Function, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
    Clin Cancer Res 9:5264-70. 2003
    ..The purpose of this study was to evaluate whether IFN therapy for chronic hepatitis C could overcome telomere reduction in the liver, a possible risk factor for hepatocellular carcinoma (HCC) development...
  5. ncbi request reprint Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation
    Nobuo Waguri
    Division of Gastroenterology and Hepatology, Department of Cellular Function, Graduate School of Medical and Dental Science, Niigata University, Niigata 951 8122, Japan
    Clin Cancer Res 9:3004-11. 2003
    ....
  6. pmc Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma
    Kenya Kamimura
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan
    BMC Gastroenterol 12:127. 2012
    ....
  7. ncbi request reprint Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis C
    Yasushi Tamura
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan
    Dig Dis Sci 54:2530-7. 2009
    ..057), and a significantly higher cumulative incidence of HCC was seen in patients with increased serum AFP levels at EOT (P = 0.021). Serum AFP level at EOT is a possible predictor of HCC in CHC patients after IFN therapy...
  8. pmc Shear wave velocity is a useful marker for managing nonalcoholic steatohepatitis
    Akihiko Osaki
    Department of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1 757 Asahimachi dori, Chuo Ku, Niigata, Niigata 951 8122, Japan
    World J Gastroenterol 16:2918-25. 2010
    ..To investigate whether a noninvasive measurement of tissue strain has a potential usefulness for management of nonalcoholic steatohepatitis (NASH)...
  9. pmc Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis
    Hirokazu Kawai
    Hirokazu Kawai, Department of Clinical Laboratory, Niigata University Medical and Dental Hospital, Niigata 951 8510, Japan
    World J Hepatol 3:15-23. 2011
    ..To reveal the manner of hepatocellular carcinoma (HCC) development in patients with nonalcoholic steatohepatitis (NASH) focusing on multicentric occurrence (MO) of HCC...
  10. doi request reprint Formula to predict platelet count after partial splenic arterial embolization in patients with hypersplenism
    Akihiko Osaki
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1 757 Asahimachi dori, Chuo Ku, Niigata, Niigata 951 8122, Japan
    J Vasc Interv Radiol 23:900-7. 2012
    ..To establish a formula to guide appropriate embolization volume for postprocedural platelet gain following partial splenic arterial embolization (PSE) for hypersplenism...
  11. doi request reprint Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment
    Yasushi Tamura
    Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Chuo Ku, Niigata, Japan
    Dig Dis Sci 55:2095-101. 2010
    ..The aim of this study was to evaluate the clinical usefulness of measuring the Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3) for prognostic predictor in patients with hepatocellular carcinoma (HCC)...
  12. doi request reprint Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM
    Atsunori Tsuchiya
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Science, Niigata University, 1 757 Asahimachi dori, Chuo Ku, Niigata, Japan
    Cancer Lett 309:95-103. 2011
    ..The 140-kDa NCAM isoform was specifically detected in the "highly soluble" NCAM group of HCC patients andits related signals are potential drug targets for NCAM+ HCC...
  13. ncbi request reprint Telomere length variation and maintenance in hepatocarcinogenesis
    Takashi Yokota
    Division of Gastroenterology and Hepatology, Department of Cellular Function, Graduate School of Medical and Dental Science, Niigata University, Niigata, Japan
    Cancer 98:110-8. 2003
    ..This study investigated the significance of telomere length variation between chromosomes with respect to the association of cancer progression and telomere length regulation...
  14. ncbi request reprint Increased hTR expression during transition from adenoma to carcinoma is not associated with promoter methylation
    Atsuo Nakamura
    Division of Gastroenterology and Hepatology, Department of Cellular Function, Graduate School of Medical and Dental Science, Niigata University, 757 Asahimachi dori 1, Niigata 951 8122, Japan
    Dig Dis Sci 49:1504-12. 2004
    ..Hypomethylation of the hTR promoter region is not likely to be the main mechanism regulating hTR expression...
  15. pmc Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4 cm
    Toshifumi Wakai
    Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1 757 Asahimachi dori, Niigata 951 8510, Japan
    World J Gastroenterol 12:546-52. 2006
    ..To determine which treatment modality--hepatectomy or percutaneous ablation--is more beneficial for patients with small hepatocellular carcinoma (HCC) (< or =4 cm) in terms of long-term outcomes...
  16. doi request reprint Successful laparoscopic division of a patent ductus venosus: report of a case
    Yoshiaki Hara
    Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1 757 Asahimachi dori, Chuo Ku, Niigata 951 8510, Japan
    Surg Today 43:434-8. 2013
    ..Although careful interventional evaluation for portal flow is absolutely imperative prior to surgery, a minimally invasive laparoscopic approach can be safely used for treating PDV...
  17. pmc Identification of cellular genes showing differential expression associated with hepatitis B virus infection
    Yasuo Fukuhara
    Yasuo Fukuhara, Takeshi Suda, Makoto Kobayashi, Yasushi Tamura, Masato Igarashi, Nobuo Waguri, Hirokazu Kawai, Yutaka Aoyagi, Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1 757 Asahimachi dori, Chuo Ku, Niigata, Niigata 951 8122, Japan
    World J Hepatol 4:139-48. 2012
    ..To investigate the impact of hepatitis B virus (HBV) infection on cellular gene expression, by conducting both in vitro and in vivo studies...
  18. ncbi request reprint Fucosylated fraction of alpha-fetoprotein, L3, as a useful prognostic factor in patients with hepatocellular carcinoma with special reference to low concentrations of serum alpha-fetoprotein
    Makoto Kobayashi
    Division of Gastroenterology and Hepatology, Department of Cellular Function, Course for Molecular and Cellular Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan
    Hepatol Res 37:914-22. 2007
    ..Conclusions: The present study indicates that the L3 fraction before treatment serves as a useful prognostic indicator when the serum concentrations of AFP were very low...
  19. pmc Low fat intake is associated with pathological manifestations and poor recovery in patients with hepatocellular carcinoma
    Kazuki Yamada
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951 8122, Japan
    Nutr J 12:79. 2013
    ..This study aimed to clarify whether dietary deviation is associated with pathological manifestations in hepatocellular carcinoma (HCC) patients...
  20. ncbi request reprint Progress toward liver-based gene therapy
    Takeshi Suda
    Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Niigata, Japan
    Hepatol Res 39:325-40. 2009
    ..This review describes the fundamentals of gene delivery, and the preclinical and clinical progress that has been made toward gene therapy using the liver as a target...
  21. doi request reprint Clinical advantage of highly sensitive on-chip immunoassay for fucosylated fraction of alpha-fetoprotein in patients with hepatocellular carcinoma
    Yasushi Tamura
    Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, 757 Asahimachi Dori 1 Bancho, Chuo Ku, Niigata 951 8520, Japan
    Dig Dis Sci 55:3576-83. 2010
    ..However, AFP-L3 has not always been reliable in cases with low serum AFP concentrations. Recently, a novel automated immunoassay for AFP-L3, the micro-total analysis system (μ-TAS), has been developed...
  22. ncbi request reprint Granulocytapheresis for the treatment of severe alcoholic hepatitis: a case series and literature review
    Kenya Kamimura
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1 757 Asahimachido ri, Chuo Ku, Niigata, 951 8510, Japan
    Dig Dis Sci 59:482-8. 2014
    ..Multidisciplinary treatment for severe alcoholic hepatitis should be considered case by case on the basis of the complexity and severity of the condition. ..
  23. doi request reprint Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment
    Yasushi Tamura
    Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, 757 Asahimachi Dori 1 Bancho, Chuo Ku, Niigata, 951 8520, Japan
    Dig Dis Sci 58:2406-12. 2013
    ..Recently, a highly sensitive immunoassay using an on-chip electrokinetic reaction and separation by affinity electrophoresis (micro-total analysis system; μTAS) has been developed...
  24. ncbi request reprint Preoperative human-telomerase reverse transcriptase mRNA in peripheral blood and tumor recurrence in living-related liver transplantation for hepatocellular carcinoma
    Yoshinobu Sato
    Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
    Hepatogastroenterology 52:1325-8. 2005
    ..In this study we evaluated the potential role of preoperative h-TERT mRNA expression in peripheral blood as a tool for predicting prognosis and tumor recurrence after living-related liver donor transplantation (LRLDT)...
  25. ncbi request reprint Bile duct involvement in a case of autoimmune pancreatitis successfully treated with an oral steroid
    Takashi Kuroiwa
    Division of Gastroenterology and Hepatology a Graduate School of Medical and Dental Sciences, Niigata University, Japan
    Dig Dis Sci 47:1810-6. 2002
    ....
  26. ncbi request reprint [Detection of HDV-RNA]
    Takeshi Suda
    Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University
    Nihon Rinsho 62:416-9. 2004
  27. doi request reprint History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction
    Yutaka Aoyagi
    Division of Gastroenterology and Hepatology, Department of Cellular Function, Course for Molecular and Cellular Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan
    J Gastroenterol Hepatol 26:615-6. 2011
    ..See article in J. Gastroenterol. Hepatol. 2011; 26: 739-744...
  28. doi request reprint Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for portosystemic shunts
    Nobuo Waguri
    Department of Gastroenterology and Hepatology, Niigata City General Hospital, 467 3 Shumoku, Chuo Ku, Niigata 950 1197, Japan
    J Vasc Interv Radiol 23:650-7. 2012
    ..To evaluate the efficacy and safety of simultaneous combined balloon-occluded retrograde transvenous obliteration (B-RTO) and partial splenic embolization (PSE) for gastric varices and/or hepatic encephalopathy...
  29. ncbi request reprint Heterogeneous hepatic enhancement on CT angiography in idiopathic portal hypertension
    Nobuo Waguri
    Division of Gastroenterology and Hepatology, Department of Cellular Function, Graduate School of Medical and Dental Science, Niigata University, 757 Asahimachi dori 1, Niigata City, Niigata 951 8122, Japan
    Liver 22:276-80. 2002
    ..Idiopathic portal hypertension is an uncommon condition characterized by presinusoidal portal perfusion disturbance without known causes...
  30. ncbi request reprint [A long-term survival case of metachronous liver metastasis from gastric cancer]
    Sou Katayanagi
    Dept of Surgery, Tokyo Medical University
    Gan To Kagaku Ryoho 34:2129-31. 2007
    ..Another metachronous liver cancer appeared in March 2006. He was treated with chemotherapy using S-1 (day 1-21) and CDDP 20 mg/m2 (day 1, 8 and 15) q5w. The size of liver metastasis was kept the same for 16 months...
  31. ncbi request reprint Remote development of hepatocellular carcinoma in patients with liver cirrhosis type B serologically cured for HBs antigenemia with long-standing normalization of ALT values
    Shogo Okoshi
    Third Department of Internal Medicine, Niigata University School of Medicine, Niigata City, Japan
    Dig Dis Sci 47:2002-6. 2002
    ..Thus, patients with liver cirrhosis due to past chronic hepatitis B should be monitored carefully for the development of HCC even if HBV infection has been serologically resolved...